Search

Your search keyword '"Filippatos, Gerasimos"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Filippatos, Gerasimos" Remove constraint Author: "Filippatos, Gerasimos" Journal journal of cardiac failure Remove constraint Journal: journal of cardiac failure
48 results on '"Filippatos, Gerasimos"'

Search Results

1. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial

3. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society

5. Galectin-3, Acute Kidney Injury and Myocardial Damage in Patients With Acute Heart Failure

8. Variation Of Prespecified Subgroups In Large-Scale HF Outcome Trials

9. Safety Indicators In Patients Receiving High-intensity Care After Acute Heart Failure Admission: The STRONG-HF Trial

10. Autonomic Regulation Therapy To Improve Symptoms And Clinical Outcomes In Patients With Heart Failure And Reduced Ejection Fraction (ANTHEM-HFrEF) Pivotal Study Results

11. Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy

12. Potential Utility of Cardiorenal Biomarkers for Prediction and Prognostication of Worsening Renal Function in Acute Heart Failure

13. Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

14. Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial

15. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial

16. Utility of Urine Neutrophil Gelatinase-Associated Lipocalin for Worsening Renal Function during Hospitalization for Acute Heart Failure: Primary Findings of the Urine N-gal Acute Kidney Injury N-gal Evaluation of Symptomatic Heart Failure Study (AKINESIS)

18. Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients with Pre Cardiogenic Shock

19. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

20. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

21. Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency

22. Galectin-3, Acute Kidney Injury and Myocardial Damage in Patients With Acute Heart Failure

23. Minimal Clinically Important Difference for Six-minute Walk Test in Patients with HFrEF and Iron Deficiency.

24. Minimal Clinically Important Difference for Six-minute Walk Test in Patients with HFrEF and Iron Deficiency

27. Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure with Reduced Ejection Fraction

31. Improvements in Signs and Symptoms During Hospitalization for Acute Heart Failure Follow Different Patterns and Depend on the Measurement Scales Used: An International, Prospective Registry to Evaluate the Evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF)

35. Clinical Predictors of QRS Duration in Patients with LBBB: Data from the AdaptResponse Trial

36. Association between Left Ventricular Ejection Fraction and Worsening Renal Function in Acute Heart Failure: Insights from the RELAX-AHF-2 Trial

38. Design and Rationale of the Soluble Guanylate Cyclase Stimulator in Heart Failure Studies (SOCRATES)

42. Functional Electrical Stimulation is More Effective in Severe Symptomatic Heart Failure Patients and Improves Their Adherence to Rehabilitation Programs

43. Changes in Dyspnea during Treatment of Acute Heart Failure Are Correlated with Clinical Signs, Rehospitalizations and Mortality. Results from the Pre-RELAX-AHF Trial

46. Prognostic Value of Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure (CHF)

48. Dissociation of Patient and Physician Assessed Symptoms during Hospitalization for Acute Heart Failure: The Measure-HF Registry

Catalog

Books, media, physical & digital resources